Dong-A Pharmaceutical Chairman to have chairmanship only

Published: 2007-02-27 06:59:00

Updated: 2007-02-27 06:59:00

I will focus on management of Dong-A Pharmaceutical as a chairman only without joining any management meetings in future, said Kang-Shin-ho, the incumbent chairman of Dong-A Pharmaceutical, Korea's largest drug maker.

I am very discouraged by Sooseok Trading's proposal to choose two executive ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK